Clinical Trial Update: Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

View source ↗

Summary

Clinical trial evaluating exosome-mediated intercellular signaling in patients with pancreatic cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Pancreatic Disease
• Pancreatic Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer, Benign Pancreatic Disease | Status: RECRUITING